Lovastatin 20-40 mg daily (in addition to low-saturated ad low-colesterol diet) reduced the incidence of first major acute cardiovascular event (MACE) during a follow-up of 5.2 years, in this study involving 5608 men and 997 women with average total cholesterol and LDL levels and low HDL levels.
AFCAPS/TexCAPS Trial
APEX Trial
ACTIVE A Trial
ASPEN Trial
PROSPER Trial
Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation
JUPITER Trial
Triage